Amin GhavamiNejad, Connor D. Flynn, Armin Geraili, Sako Mirzaie, Fatemeh Esmaeili, Hossein Zargartalebi, Sharif Ahmed, Vuslat B. Juska, Jagotamoy Das, Abdalla Abdrabou, Yi Yun Zhang, Edward H. Sargent, Shana O. Kelley
{"title":"Continuous insulin monitoring using an antibody-protecting zwitterionic microneedle patch","authors":"Amin GhavamiNejad, Connor D. Flynn, Armin Geraili, Sako Mirzaie, Fatemeh Esmaeili, Hossein Zargartalebi, Sharif Ahmed, Vuslat B. Juska, Jagotamoy Das, Abdalla Abdrabou, Yi Yun Zhang, Edward H. Sargent, Shana O. Kelley","doi":"10.1038/s41551-025-01477-7","DOIUrl":null,"url":null,"abstract":"<p>Continuous monitoring of protein and molecular biomarkers is essential for personalized disease tracking, but approaches for in vivo sensing are limited. Monitoring insulin, a peptide hormone, is an unmet need given the importance of this molecule in managing diabetes. Here we report a patch-based system with integrated electrochemical sensors that enables monitoring of insulin levels on an ongoing basis. We report a novel zwitterionic-based hydrogel microneedle patch with integrated molecular pendulum sensors that can measure insulin levels in the interstitial fluid of rats with type 1 diabetes. Our study demonstrates that the zwitterionic poly(carboxybetaine)-based microneedle patch stabilizes the antibody-based recognition elements, allowing them to withstand UV-induced crosslinking during patch fabrication and gamma-irradiation, often required for FDA-standard sterilization. We also investigate the impact of disrupted circadian rhythm on insulin levels, revealing circadian-dependent alterations in insulin absorption efficiency and distribution within the interstitial fluid and plasma. This platform not only enhances our understanding of in vivo insulin behaviour but also holds promise for personalized treatment strategies in diabetes management.</p>","PeriodicalId":19063,"journal":{"name":"Nature Biomedical Engineering","volume":"13 1","pages":""},"PeriodicalIF":26.8000,"publicationDate":"2025-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nature Biomedical Engineering","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1038/s41551-025-01477-7","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0
Abstract
Continuous monitoring of protein and molecular biomarkers is essential for personalized disease tracking, but approaches for in vivo sensing are limited. Monitoring insulin, a peptide hormone, is an unmet need given the importance of this molecule in managing diabetes. Here we report a patch-based system with integrated electrochemical sensors that enables monitoring of insulin levels on an ongoing basis. We report a novel zwitterionic-based hydrogel microneedle patch with integrated molecular pendulum sensors that can measure insulin levels in the interstitial fluid of rats with type 1 diabetes. Our study demonstrates that the zwitterionic poly(carboxybetaine)-based microneedle patch stabilizes the antibody-based recognition elements, allowing them to withstand UV-induced crosslinking during patch fabrication and gamma-irradiation, often required for FDA-standard sterilization. We also investigate the impact of disrupted circadian rhythm on insulin levels, revealing circadian-dependent alterations in insulin absorption efficiency and distribution within the interstitial fluid and plasma. This platform not only enhances our understanding of in vivo insulin behaviour but also holds promise for personalized treatment strategies in diabetes management.
期刊介绍:
Nature Biomedical Engineering is an online-only monthly journal that was launched in January 2017. It aims to publish original research, reviews, and commentary focusing on applied biomedicine and health technology. The journal targets a diverse audience, including life scientists who are involved in developing experimental or computational systems and methods to enhance our understanding of human physiology. It also covers biomedical researchers and engineers who are engaged in designing or optimizing therapies, assays, devices, or procedures for diagnosing or treating diseases. Additionally, clinicians, who make use of research outputs to evaluate patient health or administer therapy in various clinical settings and healthcare contexts, are also part of the target audience.